MCK:NYSE (USA) Also trade in: Germany Mexico UK

McKesson Corp

$ 114.1 1.61 (1.43%)
On watch
Volume: 1,193,561 Avg Vol (1m): 1,435,267
Market Cap $: 21.89 Bil Enterprise Value $: 30.03 Bil
P/E (TTM): 0.00 P/B: 2.38
Earnings Power Value -28.59
Net Current Asset Value -70.41
Tangible Book -27.39
Projected FCF 229.29
Median P/S Value 181.22
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 355.74
DCF (Earnings Based) -14.45
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.19
Equity-to-Asset 0.15
Debt-to-Equity 1.07
Debt-to-EBITDA 7.04
Interest Coverage 10.88
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.10
DISTRESS
GREY
SAFE
Beneish M-Score -2.58
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -10.5%
WACC 9.61%

Profitability & Growth : 6/10

Current vs industry vs history
Operating Margin % 1.39
Net Margin % -0.15
ROE % -3.19
ROA % -0.51
ROC (Joel Greenblatt) % 13.47
3-Year Total Revenue Growth Rate 5.20
3-Year Total EBITDA Growth Rate -28.60
3-Year EPS w/o NRI Growth Rate -65.90
N/A

» MCK's 30-Y Financials

Financials (Next Earnings Date: 2019-05-08)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:MCK

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Distribution » Medical Distribution    NAICS : 424210    SIC : 5122
Compare NYSE:CAH NYSE:ABC XKRX:091990 NAS:HSIC HKSE:01099 SHSE:601607 TSE:7459 SZSE:002589 SHSE:600056 SZSE:200028 LSE:UDG SHSE:600763 NAS:PDCO NZSE:EBO SHSE:600090 NYSE:PBH LSE:CLIN SHSE:603368 TSE:7476 NYSE:OMI
Traded in other countries 0JZU.UK
Address One Post Street, San Francisco, CA, USA, 94104
McKesson is one of three major distributors of pharmaceuticals in the U.S. The firm also has significant specialty drug and medical product wholesaling operations. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy client and pharma manufacturing suppliers.

Ratios

Current vs industry vs history
Forward PE Ratio 8.08
N/A
Price-to-Owner-Earnings 180.25
PB Ratio 2.38
PS Ratio 0.11
Price-to-Free-Cash-Flow 9.13
Price-to-Operating-Cash-Flow 7.39
EV-to-EBIT 71.15
EV-to-EBITDA 21.60
EV-to-Revenue 0.14
Shiller PE Ratio 15.16
Current Ratio 1.02
Quick Ratio 0.57
Days Inventory 30.16
Days Sales Outstanding 32.36
Days Payable 58.02

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.32
3-Year Dividend Growth Rate (Per Share) 10.60
Forward Dividend Yield % 1.37
N/A
Yield-on-Cost (5-Year) % 2.07
3-Year Share Buyback Rate 4.50

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.50
Price-to-Median-PS-Value 0.63
Earnings Yield (Joel Greenblatt) % 1.41
Forward Rate of Return (Yacktman) % 4.54

More Statistics

Revenue (TTM) (Mil) $ 213,518
EPS (TTM) $ -1.35
Beta 1.56
Volatility % 28.7
52-Week Range $ 106.11 - 160.84
Shares Outstanding (Mil) 191.83

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N